Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1928887 | 1.00 | — | — | |
| SCHEMBL14365384 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL14615529 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL3254625 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL27514978 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL13604965 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL7286427 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL7280856 | 1.00 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL2133245 | 0.97 | — | — | |
| SCHEMBL6026856 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| EP-4025675-A1 | A PERFUME OIL MIXTURE | Symrise AG (DE) | 2022-07-13 | — | — | EP | claimed |
| CN-114364773-A | Aromatic oil mixture | 西姆莱斯股份公司 | 2022-04-15 | — | — | CN | claimed |
| EP-3006547-B1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO CO LTD (JP) | 2019-10-30 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20160106637-A1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO COMPANY, LTD. (JP) | 2016-04-21 | — | — | US | claimed |
| EP-3006547-A1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | Shiseido Company Ltd. (JP) | 2016-04-13 | — | — | EP | claimed |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | KAO CORPORATION (JP) | 2010-09-30 | — | — | US | claimed |
| EP-2192178-A1 | B-GLUCURONIDASE INHIBITOR | Kao Corporation (JP) | 2010-06-02 | — | — | EP | claimed |
| WO-1998056337-A1 | MALODOR REDUCING COMPOSITION CONTAINING AMBER AND MUSK MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-17 | — | — | WO | claimed |
| EP-4136067-B1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-04-15 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-12545852-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-02-10 | — | — | US | disclosed |
| EP-3697878-B1 | USE OF ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-01-28 | — | — | EP | disclosed |
| US-12522780-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-01-13 | — | — | US | disclosed |
| EP-0012246-A1 | Aromatic and flavouring substances, their preparation by fermentation, their use and products containing them | L. Givaudan & Cie Société Anonyme (CH) | 1980-06-25 | — | — | EP | disclosed |
| US-4198532-A | 2,5,7-TIRMETHYL-OCTAN-3-OL OR 6,8-DIMETHYL-NONAN-2-OL | GIVAUDAN CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| EP-0006616-A1 | Tiglic acid ester, process for its preparation, its application and compositions containing it | L. Givaudan & Cie Société Anonyme (CH) | 1980-01-09 | — | — | EP | disclosed |
| EP-0003515-A1 | Megastigman-4,7-oxides(I) and 7-oxabicyclo(3,3,0)-octanes (II), process for the preparation of (I) and (II), use of (I) and (II) as fragrances and/or flavours, and fragrance and/or flavour compositions containing (I) or (II) | L. Givaudan & Cie Société Anonyme (CH) | 1979-08-22 | — | — | EP | disclosed |
| EP-0000719-A2 | 1,4-Epoxy-trimethyl-butenylidene-cyclohexanes (I), process for their preparation, use of (I) as fragrance and/or flavouring substance, fragrance and/or flavour compositions containing the cyclohexanes | L. Givaudan & Cie Société Anonyme (CH) | 1979-02-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545852-B2 | Odorants and compositions comprising odorants | ENY2, CDY1; CDY1B, CHRM5 | HSD11B1 1496/4885 |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | GUSB, GAA, GANAB | HSD11B1 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.